(Q53850772)

20 May 2018

title

Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients. (English)

1 reference

20 May 2018

cutaneous lupus erythematosus

main subject

1 reference

1 reference

1

1 reference

20 May 2018

author name string

Brähler S

2

1 reference

20 May 2018

Bauer R

3

1 reference

20 May 2018

Bieber T

4

1 reference

20 May 2018

Tüting T

5

1 reference

20 May 2018

language of work or name

English

0 references

publication date

1 July 2005

1 reference

20 May 2018

British Journal of Dermatology

published in

1 reference

20 May 2018

volume

153

1 reference

20 May 2018

page(s)

157-162

1 reference

20 May 2018

issue

1

1 reference

20 May 2018

Management of lupus erythematosus: recent insights

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06552.X

Lymphocytopenia in lupus erythematosus: close in vivo association to autoantibodies targeting nuclear antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06552.X

Methotrexate markedly reduces the expression of vascular E-selectin, cutaneous lymphocyte-associated antigen and the numbers of mononuclear leucocytes in psoriatic skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06552.X

Pharmacological therapy of vasculitis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06552.X

Association of inclusion body myositis with subacute cutaneous lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06552.X

Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06552.X

Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06552.X

The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06552.X

10.1111/J.1365-2133.2005.06552.X

21 January 2018

Identifiers

DOI

1 reference

20 May 2018

release_ldqlm4zvhna6ho5aubntsygany

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ldqlm4zvhna6ho5aubntsygany

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16029342

1 reference

20 May 2018